Zevin Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.23M | Sell |
75,740
-8,951
| -11% | -$618K | 0.75% | 44 |
|
|
2025
Q1 | $5.88M | Buy |
84,691
+23,983
| +40% | +$1.67M | 0.93% | 41 |
|
|
2024
Q4 | $5.22M | Buy |
60,708
+19,416
| +47% | +$1.67M | 0.77% | 40 |
|
|
2024
Q3 | $4.92M | Sell |
41,292
-1,679
| -4% | -$200K | 0.76% | 41 |
|
|
2024
Q2 | $6.13M | Buy |
+42,971
| New | +$6.13M | 0.99% | 41 |
|
|
2017
Q1 | – | Sell |
-328,360
| Closed | -$5.89M | – | 121 |
|
|
2016
Q4 | $5.89M | Sell |
328,360
-38,740
| -11% | -$695K | 1.54% | 23 |
|
|
2016
Q3 | $7.63M | Buy |
367,100
+188,280
| +105% | +$3.92M | 2.46% | 14 |
|
|
2016
Q2 | $4.81M | Buy |
178,820
+1,150
| +0.6% | +$30.9K | 1.33% | 25 |
|
|
2016
Q1 | $4.81M | Sell |
177,670
-70,410
| -28% | -$1.91M | 1.36% | 24 |
|
|
2015
Q4 | $7.2M | Buy |
248,080
+5,300
| +2% | +$154K | 1.9% | 19 |
|
|
2015
Q3 | $6.58M | Buy |
242,780
+9,380
| +4% | +$254K | 1.92% | 18 |
|
|
2015
Q2 | $6.39M | Buy |
233,400
+118,050
| +102% | +$3.23M | 1.7% | 20 |
|
|
2015
Q1 | $3.08M | Buy |
115,350
+3,690
| +3% | +$98.5K | 0.85% | 40 |
|
|
2014
Q4 | $2.36M | Sell |
111,660
-30
| -0% | -$635 | 0.66% | 54 |
|
|
2014
Q3 | $2.66M | Buy |
111,690
+2,000
| +2% | +$47.6K | 0.78% | 51 |
|
|
2014
Q2 | $2.53M | Sell |
109,690
-800
| -0.7% | -$18.5K | 0.75% | 47 |
|
|
2014
Q1 | $2.52M | Sell |
110,490
-350
| -0.3% | -$7.99K | 0.8% | 44 |
|
|
2013
Q4 | $2.05M | Buy |
110,840
+630
| +0.6% | +$11.6K | 0.58% | 51 |
|
|
2013
Q3 | $1.87M | Buy |
110,210
+4,610
| +4% | +$78K | 0.57% | 48 |
|
|
2013
Q2 | $1.64M | Buy |
+105,600
| New | +$1.64M | 0.57% | 51 |
|